Lung adenocarcinoma (LUAD) progression is strongly shaped by tumor-associated macrophages (TAMs), yet the post-transcriptional mechanisms that sustain matrix-remodeling TAM states remain incompletely understood. Here, circRNA profiling of LUAD TAMs versus normal tissue-resident macrophages identified circSMAD4 (hsa_circ_0047713) as a consistently TAM-enriched circRNA associated with advanced clinicopathological features and unfavorable survival. circSMAD4 exhibited canonical circular properties, including a validated back-splice junction, RNase R resistance, and enhanced transcript stability. Functionally, circSMAD4 knockdown in human and murine macrophages attenuated tumor education, shifted macrophages away from an M2-like phenotype, and weakened their ability to promote LUAD-cell proliferation, invasion, and EMT-like changes in co-culture. In syngeneic orthotopic lung and experimental metastasis models, circSMAD4-depleted macrophages restrained tumor growth and reduced metastatic burden. Mechanistically, cytoplasmic circSMAD4 acted as a ceRNA to sequester miR-562 and relieve repression of COL4A1. In parallel, circSMAD4 formed a specific ribonucleoprotein complex with the m6A reader IGF2BP2, facilitating IGF2BP2 association with COL4A1, ACTA2, and SPI1 transcripts and enhancing their m6A-dependent stability. Together, these dual branches converge on a matrix-remodeling output, positioning circSMAD4 as a post-transcriptional hub that reinforces protumor TAM programs in LUAD and a potential target for microenvironment-directed therapy.
CircSMAD4 shapes matrix-remodeling TAMs in lung adenocarcinoma.
阅读:2
作者:Yu Zhengwei, Wang Xinyue, Zheng Yiqian, He Yifan, Lin Jiayu, Xiao Yue, Mo Bin, Xie Haoyu, Hang Sitong, Gao Xia, Xu Pei, Liu Yihao, Xiao Haibo
| 期刊: | Non-coding RNA Research | 影响因子: | 4.700 |
| 时间: | 2026 | 起止号: | 2026 Mar 26; 19:40-57 |
| doi: | 10.1016/j.ncrna.2026.03.003 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
